Change in end systolic volume plus reduction in symptoms over 12 months [clinicaltrials_resource:8e66234800dfcac7901bb1abc20e4f6a]

Change in end systolic volume plus reduction in symptoms over 12 months [clinicaltrials_resource:8e66234800dfcac7901bb1abc20e4f6a]

Targeted LV lead placement
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:8e66234800dfcac7901bb1abc20e4f6a
Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy. [clinicaltrials:NCT00399594]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Change in end systolic volume plus reduction in symptoms over 12 months [clinicaltrials_resource:8e66234800dfcac7901bb1abc20e4f6a]

Targeted LV lead placement
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:8e66234800dfcac7901bb1abc20e4f6a
Bio2RDF identifier
8e66234800dfcac7901bb1abc20e4f6a
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8e66234800dfcac7901bb1abc20e4f6a
measure [clinicaltrials_vocabulary:measure]
Change in end systolic volume plus reduction in symptoms
time frame [clinicaltrials_vocabulary:time-frame]
description
Targeted LV lead placement
identifier
clinicaltrials_resource:8e66234800dfcac7901bb1abc20e4f6a
title
Change in end systolic volume plus reduction in symptoms over 12 months
@en
inDataset
type
label
Change in end systolic volume ...... 6234800dfcac7901bb1abc20e4f6a]
@en